Возраст домена | 20 лет |
Дата окончания | Истек срок регистрации |
PR | 1 |
ИКС | |
Страниц в Google | 31 |
Страниц в Яндексе | 17 |
Dmoz | Нет |
Яндекс Каталог | Нет |
Alexa Traffic Rank | 17170831 |
Alexa Country | Нет данных |
История изменения показателей | Авторизация |
Идет сбор информации... Обновить
Astellas Pharma Ltd | Astellas Pharma UK
n/a
This website is intended for a UK audience. Astellas Pharma Ltd is improving the future of patients in four key therapeutic areas.
UTF-8
19.12 КБ
288
2 293 симв.
1 939 симв.
Данные предоставлены сервисом semrush
Сайт | Общие фразы | PR | тИЦ | Alexa Rank | Alexa Country | |
---|---|---|---|---|---|---|
![]() ![]() |
9 | 6 |
0 | 207418 | ![]() | |
![]() ![]() |
6 | 9 |
0 | 25 | ![]() | |
![]() |
6 | 5 |
0 | 5267637 | ![]() |
|
![]() |
5 | 3 |
0 | 8338986 | ![]() |
|
![]() |
5 | 6 |
0 | 750482 | ![]() | |
![]() |
4 | 7 |
0 | 408 | ![]() | |
![]() ![]() |
2 | 8 |
0 | 654 | ![]() | |
![]() ![]() |
2 | 8 |
0 | 9090 | ![]() | |
![]() ![]() |
2 | 7 |
0 | 3848 | ![]() | |
![]() ![]() |
2 | 8 |
0 | 563 | ![]() | |
Еще 23 сайта после авторизации |
Данные предоставлены сервисом semrush
Счетчик | Посетители за 24 часа | Просмотры | Просмотров на посетителя |
---|---|---|---|
![]() | Нет доступа | Нет доступа | n/a |
Данные linkpad ( 10 Апреля 2014 ) | |
Количество ссылок на сайт | 1 |
Количество доменов, которые ссылаются на сайт | 1 |
Количество найденных анкоров | 1 |
Исходящие (внешние) ссылки домена | 28 |
Количество доменов, на которые ссылается сайт | 1 |
Количество исходящих анкоров | 1 |
Внешние ссылки главной страницы ( 1 ) | |
astellas.eu | <img> |
Внутренние ссылки главной страницы ( 33 ) | |
#content | skip to main content |
/cookies-policy/ | manage cookies |
astellas.co.uk/ | Home |
astellas.co.uk/about/about/ | About |
astellas.co.uk/about/uk-company-culture/ | Astellas Pharma Ltd |
astellas.co.uk/about/changing-tomorrow/ | CHANGING TOMORROW™ |
astellas.co.uk/therapy-areas/about/ | About |
astellas.co.uk/therapy-areas/oncology/ | Oncology Our commitment is to developing first-in-class and best-in-class therapies |
astellas.co.uk/therapy-areas/transplantation/ | Transplantation Well established therapies to prevent organ rejection after transplantation |
astellas.co.uk/therapy-areas/urology/ | Urology Leading research to satisfy unmet patient needs in urological conditions |
astellas.co.uk/therapy-areas/anti-infectives/ | Anti-Infectives Addressing the complex challenges of serious fungal and bacterial infections |
astellas.co.uk/rd/research-development/ | Research & Development |
astellas.co.uk/rd/rd-strategy/ | R&D Strategy |
astellas.co.uk/clinical-trials-information/ | Clinical Trials Info |
astellas.co.uk/responsibility/responsibility/ | Responsibility |
astellas.co.uk/responsibility/corporate-social-responsibilit... | Corporate Social Responsibility |
astellas.co.uk/responsibility/astellas-group-code-of-conduct... | Astellas Group Code of Conduct |
astellas.co.uk/responsibility/modern-slavery-act/ | Modern Slavery Act |
astellas.co.uk/2017-gender-pay-gap-report/ | 2017 Gender Pay Gap Report |
astellas.co.uk/transparency/interactions-with-hcps/ | Interactions with HCPs |
astellas.co.uk/transparency/megs/ | MEGS |
astellas.co.uk/transparency/supporting-patients/ | Supporting Patients |
astellas.co.uk/transparency/joint-working/ | Joint Working |
astellas.co.uk/news/ | News |
astellas.co.uk/careers/ | Careers |
astellas.co.uk/contact/ | <img> |
/therapy-areas/about/ | CHANGING TOMORROW™ We strive to be best-in-class in therapeutic areas where there is a vital need for treatments that aim to imp... |
/about/changing-tomorrow/ | Everyone at Astellas knows that our continuing success lies in our potential for CHANGING TOMORROW™. More |
/site-map/ | Site Map |
/procurement/ | Procurement |
astellas.co.uk/privacy-policy/ | Privacy Policy |
astellas.co.uk/terms-of-use/ | Copyright © 2019 Astellas Pharma |
astellas.co.uk/cookies-policy/ | Cookies Policy |
Domain name:
astellas.co.uk
Data validation:
Nominet was able to match the registrant's name and address against a 3rd party data source on 17-Jan-2013
Registrar:
Markmonitor Inc. t/a MarkMonitor Inc. [Tag = MARKMONITOR]
URL: http://www.markmonitor.com
Relevant dates:
Registered on: 17-May-2004
Expiry date: 17-May-2019
Last updated: 15-Apr-2017
Registration status:
Registered until expiry date.
Name servers:
ns1.markmonitor.com
ns2.markmonitor.com
ns3.markmonitor.com
ns4.markmonitor.com
ns5.markmonitor.com
ns6.markmonitor.com
ns7.markmonitor.com
WHOIS lookup made at 18:45:07 17-Jan-2019
--
User-agent: *
Disallow: /wp-admin/
Allow: /wp-admin/admin-ajax.php
США - 204.179.240.180
США - Нью-Йорк - 69.191.242.22
Bloomberg, LP
Verizon Business
Bloomberg Financial Market
HTTP/1.1 200 OK
Date: Sun, 13 Jan 2019 06:38:09 GMT
Server: Apache/2.2.15 (CentOS)
X-Powered-By: PHP/7.1.25
Link: ; rel="https://api.w.org/", ; rel=shortlink
Strict-Transport-Security: max-age=63072000; includeSubdomains;
X-Frame-Options: SAMEORIGIN
X-XSS-Protection: 1; mode=block
Connection: close
Transfer-Encoding: chunked
Content-Type: text/html; charset=UTF-8
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"